Cover Image
Read Now

Optimal Use of Sandimmun® in Nephrotic Syndrome

Since 1978, when Sandimmun was first used in humans, great experience has been gathered in clinical transplantation by the treatment of about half a million patients. The experience with Sandimmun in nephrotic syndrome is put into perspective and compared with alternatives such as corticosteroids an...

Full description

Bibliographic Details
Main Authors: Meyrier, A., Niaudet, P. (Author), Brodehl, J. (Author)
Format: eBook
Language:English
Published: Berlin, Heidelberg Springer Berlin Heidelberg 1992, 1992
Edition:1st ed. 1992
Subjects:
Nephrology
Immunology
Allergy
Allergology
Pharmacology
Pharmacology/toxicology
Online Access:
Collection: Springer Book Archives -2004 - Collection details see MPG.ReNa
Table of Contents:
  • 1 Introduction
  • 2 Background
  • 2.1 The glomerulus and the glomerular barrier to proteins
  • 2.2 Nephrotic syndrome
  • 2.3 Mode of action of Sandimmun in NS
  • 3 Idiopathic nephrotic syndrome (nephrosis)
  • 3.1 Minimal change disease
  • 3.2 Focal segmental glomerulosclerosis
  • 3.3 Treatment of nephrosis
  • 4 Idiopathic membranous glomerulopathy
  • 4.1 Definition
  • 4.2 Clinical course
  • 4.3 Treatment
  • 5 Sandimmun in other etiologies of nephrotic syndrome
  • 5.1 Lupus nephritis
  • 5.2 IgA nephropathy
  • 5.3 Proliferative glomerulonephritis
  • 5.4 Other glomerulopathies
  • 6 Guidelines for the use of Sandimmun in nephrotic syndrome
  • 6.1 Patient selection
  • 6.2 Dosage
  • 6.3 Monitoring
  • References

Similar Items